» Articles » PMID: 19944162

Inhibition of Anticancer Drug Efflux Transporter P-glycoprotein by Rosemary Phytochemicals

Overview
Journal Pharmacol Res
Publisher Elsevier
Specialty Pharmacology
Date 2009 Dec 1
PMID 19944162
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of dietary antioxidative and chemopreventive rosemary phytochemicals on the function of the human drug efflux transporter P-glycoprotein (MDR1, ABCB1) and multidrug resistance protein 1 (MRP1, ABCC1) were investigated using P-glycoprotein-overexpressing human carcinoma KB-C2 cells and human MRP1 gene-transfected KB/MRP cells. The effects of natural phytochemicals found in rosemary such as carnosic acid, carnosol, rosmarinic acid, and ursolic acid were investigated. The accumulation of daunorubicin or rhodamine 123, fluorescent substrates of P-glycoprotein, in KB-C2 cells increased in the presence of carnosic acid, carnosol, and ursolic acid in a concentration-dependent manner. In contrast, carnosic acid, carnosol, rosmarinic acid, and ursolic acid had no effects on the accumulation of calcein, a fluorescent substrate of MRP1, in KB/MRP cells. The ATPase activities of P-glycoprotein were stimulated by carnosic acid, carnosol, and ursolic acid. KB-C2 cells were sensitized to vinblastine cytotoxicity by carnosic acid, showing that carnosic acid reverses multidrug resistance. These results suggest that rosemary phytochemicals, such as carnosic acid, have inhibitory effects on anticancer drug efflux transporter P-glycoprotein and may become useful to enhance the efficacy of cancer chemotherapy.

Citing Articles

Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters.

Kulkarni C, Yang J, Koleske M, Lara G, Alam K, Raw A Pharmaceutics. 2024; 16(5).

PMID: 38794309 PMC: 11124870. DOI: 10.3390/pharmaceutics16050647.


Achievement of the Selectivity of Cytotoxic Agents against Cancer Cells by Creation of Combined Formulation with Terpenoid Adjuvants as Prospects to Overcome Multidrug Resistance.

Zlotnikov I, Dobryakova N, Ezhov A, Kudryashova E Int J Mol Sci. 2023; 24(9).

PMID: 37175727 PMC: 10178335. DOI: 10.3390/ijms24098023.


Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier.

Martins-Gomes C, Silva A J Xenobiot. 2023; 13(2):172-192.

PMID: 37092502 PMC: 10123636. DOI: 10.3390/jox13020014.


Application Prospects of FTIR Spectroscopy and CLSM to Monitor the Drugs Interaction with Bacteria Cells Localized in Macrophages for Diagnosis and Treatment Control of Respiratory Diseases.

Zlotnikov I, Ezhov A, Vigovskiy M, Grigorieva O, Dyachkova U, Belogurova N Diagnostics (Basel). 2023; 13(4).

PMID: 36832185 PMC: 9954918. DOI: 10.3390/diagnostics13040698.


Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.

Emran T, Shahriar A, Mahmud A, Rahman T, Abir M, Siddiquee M Front Oncol. 2022; 12:891652.

PMID: 35814435 PMC: 9262248. DOI: 10.3389/fonc.2022.891652.